We are live on ! Find out more
CPI

Canaan Partners IX Portfolio holdings

AUM $87.5M
This Fund
S&P 500
This Quarter Est. Return
-20.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$43.4M
AUM Growth
-$19.6M
Cap. Flow
-$7.3M
Cap. Flow %
-16.84%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CTMX icon
CytomX Therapeutics
CTMX
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTMX icon
1
CytomX Therapeutics
CTMX
$788M
$43.4M 100%
4,244,381
-640,374
-13% -$7.3M

Similar funds

HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
CCFP
Charles Carroll Financial Partners Kingston, Massachusetts $93M AUM 39.93% 1-Year Est. Return
PC
Pavadi Capital New York $81.2M AUM 5.26% 1-Year Est. Return
BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return

Canaan Partners IX's Q2 2016 Portfolio in Review

As of Q2 2016, Canaan Partners IX held 1 position worth $43.4M, down 31% from $63M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners IX withdrew a net $7.3M in Q2 2016, reducing 1 holding. Its largest reduction was CytomX Therapeutics, cutting an estimated $7.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Canaan Partners IX's biggest Q2 2016 reduction was CytomX Therapeutics, cutting an estimated $7.3M.
  • Canaan Partners IX's ten largest holdings make up 100% of its $43.4M portfolio in Q2 2016.
  • Canaan Partners IX opened 0 new positions and closed 0 in Q2 2016.
  • Canaan Partners IX's portfolio value fell 31% quarter-over-quarter to $43.4M.

Based on Canaan Partners IX's 13F filing for Q2 2016, filed 6 Jul 2016.